ATRC - エイトリキュア (AtriCure Inc.)

ATRCのニュース

   Radiofrequency Ablation Device Market - Boston Scientific, St Jude Medical, Medtronic, Covidien and Stryker, Imricor Medical Systems, AtriCure, BIOTRONIK, MicroPort Scientific and Spacelabs Healthcare.  2021/06/28 13:30:33 OpenPR
Coherent Market Insights has announced the addition of the Global Radiofrequency Ablation Device Market Size, Status and Forecast 2027, The report classifies the market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well
   AtriCure tops list of Cincinnati public companies that pay their employees the most  2021/06/18 08:14:04 Business Journals
AtriCure tops list of Cincinnati public companies that pay their employees the most - Cincinnati Business Courier Cincinnati Business Courier
   Appointments and advancements for June 15, 2021  2021/06/15 16:00:00 BioWorld
New hires and promotions in the med-tech industry, including: Adapthealth, Atricure, Augmedix, Deepcell, Edap Tms, Endra, Helius Medical Technologies, One Drop, Ortho Regenerative Technologies, Quil, Stentit, Talkspace.
   AtriCure Names Two New Members to the Board of Directors  2021/06/15 11:00:00 Business Wire
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that Deborah H. Telman and Maggie Yuen have been elected to its Board of Directors. Ms. Telman has spent over 20 years in senior executive roles at global companies. She is Executive Vice President and General Counsel for Organon (NYSE: OGN), a global healthcare company formed in June 2021 through a spinoff from
   Cryotherapy Ablation Device Market Development, Market Trends, Key Driven Factors, Segmentation And Forecast To 2021-2027| Icecure Medical, AtriCure, Medtronic  2021/06/08 13:10:46 Jumbo News
Los Angeles, United State: The report is a compilation of comprehensive research studies on various aspects of the global Cryotherapy Ablation Device Market. With accurate data and highly authentic information, it makes a brilliant attempt to provide a real, transparent picture of current and future situations of the global Cryotherapy Ablation Device market. Market participants []
   Cardiac Prosthetic Devices Market | Abbott Laboratories, Abiomed, Inc., AtriCure, Inc., Boston Scientific Corporation, Edward Lifesciences Corporation BIOTRONIK, Braile Biomedica, CryoLife, Inc., Labcor Laboratrios  2021/03/23 05:50:11 OpenPR
Cardiac Prosthetic Devices Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players
   Radiofrequency Ablation Devices Market Overview, Top Players Analysis, Business Development Strategies and Sales Revenue 2027 | AngioDynamics, Inc., Hologic, Inc., AtriCure, Inc., and Johnson & Johnson  2021/03/17 13:06:22 OpenPR
A new report published by Allied Market Research titled, "Radiofrequency Ablation Devices Market was valued at $1,729 million in 2015, and is expected to reach $3,785 million by 2022, supported by a CAGR of 11.8% during the forecast period 2016-2027" Download
   Atrial Fibrillation Market to reach US$ 18,085.96 million by 2027 and to grow at a CAGR of 14.0% - AtriCure, Biosense Webster, CardioFocus, Biotronik  2021/03/08 06:59:41 OpenPR
Atrial fibrillation also referred to as AFib or AF is a medical condition that causes irregular heartbeat (arrhythmia) and which can further lead to blood clots, stroke, heart failure and other heart-related complications. The global atrial fibrillation market is driven
   AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy  2021/01/04 13:00:00 Business Wire
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of additional labeling claims for cryo nerve block (cryoNB) therapy to include the treatment of adolescent patients (12-21 years of age). The cryoICE® and cryoSPHERE™ cryoablation probes are designed to temporarily block pain by ablati
   AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference  2020/11/19 13:00:00 Business Wire
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will participate in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference. Conference Dates: Tuesday, December 1 to Thursday December 3, 2020 A link to the fireside chat presentation will be available on the “Investors” section of the Company’s website at https://ir.atric
   Cardiac Prosthetic Devices Market | Abbott Laboratories, Abiomed, Inc., AtriCure, Inc., Boston Scientific Corporation, Edward Lifesciences Corporation BIOTRONIK, Braile Biomedica, CryoLife, Inc., Labcor Laboratrios  2021/03/23 05:50:11 OpenPR
Cardiac Prosthetic Devices Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players
   Radiofrequency Ablation Devices Market Overview, Top Players Analysis, Business Development Strategies and Sales Revenue 2027 | AngioDynamics, Inc., Hologic, Inc., AtriCure, Inc., and Johnson & Johnson  2021/03/17 13:06:22 OpenPR
A new report published by Allied Market Research titled, "Radiofrequency Ablation Devices Market was valued at $1,729 million in 2015, and is expected to reach $3,785 million by 2022, supported by a CAGR of 11.8% during the forecast period 2016-2027" Download
   Atrial Fibrillation Market to reach US$ 18,085.96 million by 2027 and to grow at a CAGR of 14.0% - AtriCure, Biosense Webster, CardioFocus, Biotronik  2021/03/08 06:59:41 OpenPR
Atrial fibrillation also referred to as AFib or AF is a medical condition that causes irregular heartbeat (arrhythmia) and which can further lead to blood clots, stroke, heart failure and other heart-related complications. The global atrial fibrillation market is driven
   AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy  2021/01/04 13:00:00 Business Wire
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of additional labeling claims for cryo nerve block (cryoNB) therapy to include the treatment of adolescent patients (12-21 years of age). The cryoICE® and cryoSPHERE™ cryoablation probes are designed to temporarily block pain by ablati
   AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference  2020/11/19 13:00:00 Business Wire
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will participate in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference. Conference Dates: Tuesday, December 1 to Thursday December 3, 2020 A link to the fireside chat presentation will be available on the “Investors” section of the Company’s website at https://ir.atric

calendar